OM1 Doubles Lupus Dataset, Representing 56,000+ Patients Prospectively Followed With Deep Clinical Data
OM1, a leading real-world data, outcomes and technology company with a focus on chronic conditions, today announced the expansion of its lupus dataset, PremiOM™ SLE.
› READ THE RELEASEPOSTERS
Real-World Characterization and Management of Alopecia Areata Patients in the U.S.
MAY 16, 2023
View our poster on Real-World Characterization and Management of Alopecia Areata Patients in the U.S. Click to view!
Machine Learning Models to Estimate Disease Activity Measures in RealWorld Data Sources: Lessons Learned from Four Autoimmune Diseases
MAY 16, 2023
View our poster on Machine Learning Models to Estimate Disease Activity Measures in RealWorld Data Sources: Lessons Learned from Four Autoimmune Diseases. Click to view!
EVENTS
American Psychiatric Association Annual Meeting
MAY 16, 2023
When: May 20-24 Where: Moscone Center, San Fransisco, CA Booth Location: 1135 Events On Site: Panel Presentation Treatment Resistant Depression from Multiple Perspectives: Does It Exist? In partnership with Compass Pathways Saturday, May 20 1:30 pm – 3:00 pm Room 303 Moscone South Poster Presentation Use of Medical Language Processing in Real-World Data to Understand[…]
ISPOR Annual Meeting
MAY 16, 2023
When: May 6-10 Where: Boston Convention and Exhibit Center, Boston, MA Booth Location: 716 Events On Site: Poster Presentations Real-World Characterization and Management of Alopecia Areata Patients in the U.S. Monday, May 8, 2023 Poster Session 2 Poster Code: RWD62 Poster session time: 3:15 PM – 6:45 PM Presentation time: 5:45 PM – 6:45 PM[…]
EBOOKS
Analyses & Insights from the OM1 Lupus Data Network Ebook
MAY 16, 2023
At OM1, we use RWD to create digital data networks to answer research questions and improve patient outcomes. In this E-Book you will find a sampling of: Market trends Data on Lupus Subtypes Artificial Intelligence Applications Case studies And more! Download>> *Due to proprietary information contained in our materials, we do not currently distribute them[…]
Analyses & Insights from OM1 Heart Failure Specialty Data
MAY 16, 2023
At OM1, we use both RWD to create digital data networks and AI powered tools to answer research questions and improve patient outcomes. In this E-Book you will find a new chapter with insights into sex and social determinants of health, case studies, solutions and considerations in AI and predictive modeling. Download>> *Due to proprietary[…]
VIDEOS
Multiple Sclerosis eEDSS – Data Science Point of View
APR 13, 2023
Costas Boussios, Chief Data Scientist, OM1 details estimated EDSS score for Multiple Sclerosis were developed.
NEWS & ARTICLES
“I Know It When I See It”: Definitions of Treatment-Resistant Depression
MAY 26, 2023
Psychiatric Times May 25, 2023 Leah Kuntz Read the full article>> Presenters at the 2023 APA Annual Meeting compared definitions of treatment-resistant depression. CONFERENCE REPORTER “In 1964, Supreme Court Justice Potter Stewart was asked for his test for obscenity and his response famously was, ‘I know when I see it.’ In the real world and[…]
How Real-World Data Can Contribute to Improved Mental Health Treatment
MAY 26, 2023
PM360 MAY 25, 2023 Andrew Matthius Read the full article>> Mental health continues to be a national crisis that is only becoming more prevalent, especially since the pandemic. According to the National Alliance on Mental Illness (NAMI), 22.8% of U.S. adults experienced mental illness in 2021, which represents about 1 in 5 adults or 57.8 million[…]
WHITE PAPERS
From Big Data to Measurable Outcomes: OBC
JUL 6, 2017
A heightened focus on value is driving efforts across health care to improve outcomes and reduce costs. For pharmaceutical companies, this focus translates into a shift away from traditional payment models to more outcomes-based, risk sharing agreements. In many ways, these agreements present the opportunity to better align interests across health care’s stakeholders. However, they[…]
Improving Performance under Bundled Care
NOV 5, 2016
The field of medicine is changing rapidly due to two major disruptions – the application of artificial intelligence, such as machine and deep learning and the shift from fee-for-service to value-based payment models. These innovations, which are occurring simultaneously, are fundamentally altering how data are used and how care is provided. To survive in this[…]
WEBINARS
Improving Patient Outcomes: AI-Based Phenotyping for Diagnosis, Treatment, and Clinical Trials
JUN 7, 2023
Register to watch>> Join a panel of OM1’s clinical experts in cardiometabolic disease, immunology, and mental health as they explore how Artificial Intelligence (AI) can find phenotypic patterns and unlock insights hidden in real-world data. Extracting as much information as possible from real-world datasets is essential for understanding the complete patient journey. Subtle patterns in[…]
Using AI to Expand Treatment Access and Close Guideline Gaps
MAY 16, 2023
Tue, Jun 20, 2023 11:00 AM – 12:00 PM EDT Presenters: Costas Boussios, Chief Data Scientist and Joseph Zabinski, Managing Director of AI & Personalized Medicine Register>> Across many conditions, screening for diagnosis and use of effective therapies remain far behind where best-practice clinical guidelines would suggest. Patients falling into this ‘guidelines gap’ may not[…]